• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respirol Case Rep . Development of bullous lung disease with pneumothorax following SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Respirol Case Rep


. 2022 Aug 2;10(9):e01013.
doi: 10.1002/rcr2.1013. eCollection 2022 Sep.
Development of bullous lung disease with pneumothorax following SARS-CoV-2 infection


Hafizah Abdullah[SUP] 1 [/SUP], Yen Shen Wong[SUP] 2 [/SUP], Muhammad Amin Ibrahim[SUP] 2 [/SUP], Aisya Natasya Musa[SUP] 2 [/SUP], Thevaraajan Jayaraman[SUP] 2 [/SUP], Mohd Arif Mohd Zim[SUP] 2 [/SUP]



Affiliations

Abstract

Cystic lung formation secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was described during coronavirus disease pandemic, but with relatively low prevalence. A rare yet under-recognized complication is that these cystic areas may progress to bullae, cavities and pneumothorax. We reported two cases of ruptured bullae with pneumothorax following SARS-CoV-2 infection. Two patients were discharged following SARS-CoV-2 pneumonia, which did not require invasive mechanical ventilation (IMV). However, both patients presented again a month later with shortness of breath. Repeated computed tomography (CT) thorax showed development of bullous lung disease and pneumothorax. The first patient underwent surgical intervention whilst the second patient was treated conservatively. Development of bullous lung disease following SARS-CoV-2 infection is rare but may be associated with serious morbidity. Patients whose general condition permits should be offered surgical intervention whilst conservative management is reserved for non-surgical candidates.

Keywords: bullous lung disease; pneumothorax; severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
 
Back
Top Bottom